Thursday, July 23, 2026

 

How a pandemic detour helped researchers uncover clues to a mysterious disease




Michigan State University






EAST LANSING, Mich. – When the COVID-19 pandemic shut down international travel in 2020, Michigan State University researcher Eric Benbow faced a problem.

A $2.5 million research project designed to study an environmental pathogen in South America was suddenly on hold. With fieldwork canceled and uncertainty surrounding when travel might resume, Benbow and his collaborators needed a new plan.

That unexpected detour led to a surprising discovery — and new insights into a disease that has puzzled scientists for decades.

In a study published in Communications Medicine, an international team of researchers examined the environmental and human factors that influence the distribution of Buruli ulcer, a neglected tropical disease caused by the bacterium Mycobacterium ulcerans. The work helps explain how ecosystems, climate, land use and human activities interact to shape disease risk.

“People often think about infectious diseases in terms of person-to-person transmission,” said Benbow, professor in the Department of Entomology in the College Agriculture and Natural Resources and in the Department of Osteopathic Medical Specialties in the College of Osteopathic Medicine. “But this pathogen lives in the environment. To understand the disease, we have to understand the ecosystem.”

Buruli ulcer is most common in parts of West and Central Africa and can cause severe skin ulcers, scarring and disability. Yet despite decades of study, scientists still do not fully understand how people become infected.

“It’s been called the ‘mysterious disease’ for decades because no one really knew how it was transmitted,” Benbow said.

Using hundreds of environmental variables, researchers identified patterns linking disease occurrence to factors such as flooding, land disturbance, agriculture, invasive plant species and climate conditions.

The findings support a growing body of research showing that environmental change can influence where pathogens persist and where people are most likely to encounter them.

“We’ve been taking a One Health approach to this disease for more than 15 years,” Benbow said. “You can’t separate human health from environmental health.”

The study also builds on an unexpected discovery made during the pandemic.

Unable to travel to South America, Benbow’s team shifted its attention to the southeastern United States after uncovering an old study suggesting the pathogen might exist there. Using newer molecular tools, the researchers sampled aquatic habitats across the region and confirmed the bacterium’s presence.

We found it,” Benbow said.

The researchers later found other areas in the U.S. that are favorable and, therefore, were able to expand the known environmental range of the pathogen. Combined with the study’s global modeling results, the findings suggest that suitable environmental conditions for Mycobacterium ulcerans may exist in more places than previously recognized, even where human cases of Buruli ulcer have not been reported.

That discovery aligned with the new global modeling work, which identified portions of the southeastern United States as environmentally suitable for the pathogen, despite no known locally acquired human cases of Buruli ulcer.

The question now is why.

“Why are people getting the disease in some places and not others?” Benbow said. “That’s one of the major questions we’re trying to answer.”

While the study focuses on Buruli ulcer, Benbow says the broader implications extend far beyond a single disease.

“We’re using Buruli ulcer as a model system,” he said. “The larger question is how environmental change influences disease risk.”

Researchers increasingly recognize that human health is connected to the health of ecosystems. Changes such as agricultural expansion, invasive species, urban growth, mining and shifting climate conditions can alter where pathogens persist, how they disperse and how people encounter them.

By identifying the environmental conditions associated with disease-causing organisms, scientists can better anticipate future risks, improve surveillance efforts and help public health officials focus resources in areas where disease emergence may be more likely.

“The goal isn’t just to understand where a disease is today,” Benbow said. “It’s to understand the conditions that allow it to emerge so we can be better prepared for what’s coming next. These pathogens don’t suddenly appear out of nowhere. Many are already part of the natural environment. The challenge is understanding what conditions allow them to become a threat. When we alter landscapes, we can sometimes wake sleeping giants.”

The study included researchers from Michigan State University, Mississippi State University, the University of Montpellier and several international institutions.

MSU has a satellite uplink/LTN TV studio and Comrex line for radio interviews upon request.

Contact: Kim Ward: 734-224-8377, kward@msu.edu

###

Michigan State University has been advancing the common good with uncommon will for more than 170 years. Among the world’s top 100 universities and a leading U.S. public research institution, MSU pushes the limits of discovery and innovation to advance the state of Michigan and the nation, and make a better, safer, healthier world for all. The university provides life-changing educational opportunities through an inclusive academic community with more than 400 programs of study and is the largest producer of talent for Michigan, educating more undergraduates than any other university in the state.

 

For generations, Spartans have changed lives through research and innovation. Support from federal, state and local funding helps power discoveries that improve health, strengthen communities and keep America at the forefront of innovation and competitiveness. From lifesaving cancer treatments to advances in agriculture, energy and technology, see how Michigan State University researchers are shaping a better future for Michigan and the world. 

For MSU news on the web, go to MSUToday or x.com/MSUnews.

 

 

Research success in the search for new reserve antibiotics



Chemists from the University of Magdeburg succeed for the first time in synthesizing the highly effective naturally occurring substance, Neosorangicin 



Otto-von-Guericke-Universität Magdeburg

Prof. Dieter Schinzer 

image: 

Prof. Dieter Schinzer in his laboratory at the Institute of Chemistry at the University of Magdeburg. 

view more 

Credit: Jana Dünnhaupt/University of Magdeburg





In order to artificially produce the naturally occurring substance, the scientists used what is known as relay synthesis - instead of immediately creating the entire complex molecule, they first synthesized the critical sections, which served as staging posts en route to the complete substance. The research success does not lie solely in the components produced, but in the proof of the development process.

The results have just been published in the renowned specialist scientific journal, Chemistry - A European Journal from Wiley-VCH, one of the leading scientific publishers in chemistry and materials science.

 

Neosorangicin A

Neosorangicin A is what is known as a secondary metabolite that is produced by myxobacteria in order to compete with other microorganisms. Existing research has shown that Neosorangicin A interferes in a central process in the bacteria in that it inhibits the bacterial RNA polymerase, that is, the enzyme that bacteria need in order to read their genetic information and multiply. So far, the substance has been effective against various groups of bacteria, including gram negative pathogens. These bacteria are increasingly causing problems for hospitals worldwide and are particularly difficult to treat, because they possess an additional protective outer layer that repels many active ingredients. Neosorangicin A is thus one of a class of substances that are of particular interest for the development of future reserve antibiotics.

“We are working here with a molecule that is extremely exciting biologically, but which in chemical terms poses great difficulties to study,” says Professor Dieter Schinzer. “The method of synthesis that has now been developed is the prerequisite for making targeted changes to the natural substance and making it more stable and thus usable for further active ingredient development.”

 

The Synthesis

Schinzer goes on to say that the challenging part of the synthesis was that Neosorangicin A is not only a really large molecule, but also that its three-dimensional structure is highly complex. “The molecule contains 16 so-called chiral centers, or in other, simpler, words places where the spatial arrangement of the atoms has to be extremely precise. Even the tiniest deviations can be critical when it comes to a substance fitting in the molecular “pocket” of its target protein or remaining ineffective.” Added to this, Neosorangicin A is relatively unstable and can be quickly degraded in the body. “And this is precisely why a chemical approach is so important. Only now that we have succeeded in replicating the molecule in the laboratory can it be chemically altered in targeted fashion and biologically optimized.”

Professor Schinzer and his team developed a convergent synthesis strategy. Instead of building the complex molecule in a long sequence step by step, the researchers initially produced three highly complex key building blocks separately and only combined them with one another at the end of the process. The production of individual sub-structures required up to 19 chemical reaction steps. With special coupling reactions they ultimately succeeded in building the complete carbon skeleton of Neosorangicin A.

 

Worldwide antibiotic resistance

The World Health Organization (WHO) considers antibiotic resistance to be among the greatest threats to global health. A global analysis published in 2024 in The Lancet estimated tresistance,1 around 1.14 million deaths were directly caused by bacterial resistance, and 4.71 million deaths were associated with it. By 2050, every year up to 1.91 million people could die directly as a result of resistant bacterial infections, if no more effective countermeasures are developed.

“Resistant infections are no longer an abstract future scenario, but instead have long been a global medical problem,” says Professor Schinzer. “We need new types of structure because many of the traditional antibiotics are losing their effectiveness. Natural substances such as Neosorangicin A can provide important models for this, but only if we learn how to control them chemically.”

Professor Schinzer adds that there is still a long way to go before an effective drug can be produced. The successful synthesis of Neosorangicin A does, however, provide a crucial foundation for this by making what has until now been a difficult to access natural substance chemically available and alterable. “This means that in future, more stable variants can be developed, biological effects tested and possible new drug candidates systematically investigated.

The research project, which was entitled “SME Innovative-21: NEOSORA” was supported by, among others, the Federal Ministry of Research, Technology and Space (BMFTR) within the SME Innovative program as well as the European Fund for Regional Development (EFRD) (ZS/2024/01/183363).

The Helmholtz Center for Infection Research supplied the natural reference sample of Neosorangicin A.

 

Natural compounds against sarcoma. Which shows the greatest potential?



Laboratory study identifies curcumin as the plant-derived compound with the most balanced combination of anticancer activity and safety against fibrosarcoma cells.




Wroclaw Medical University

Prof. Julita Kulbacka 

image: 

Prof. Julita Kulbacka, corresponding author of the study and researcher at Wroclaw Medical University.

view more 

Credit: Wroclaw Medical University





Curcumin, berberine, and other plant-derived compounds have long attracted scientific interest because of their anti-inflammatory and anticancer properties. A new study by researchers from Wroclaw Medical University and the University of Wroclaw, however, shows that not all natural compounds act in the same way, and strong anticancer activity does not always go hand in hand with a good safety profile. 

The researchers compared five compounds: curcumin, berberine, biochanin A, cucurbitacin E, and CAPE (caffeic acid phenethyl ester), a component of propolis. They investigated how these substances affected fibrosarcoma cells and healthy muscle cells. 

A cellular control switch 

The study focused on the NF-κB signaling pathway, which regulates inflammation, metabolism, cell survival, and cellular aging. 

NF-κB acts like a central control switch that integrates cellular stress signals and determines whether a cell activates inflammatory pathways, fights for survival or changes its metabolism, - explains Prof. Julita Kulbacka from the Department of Molecular and Cellular Biology at Wroclaw Medical University. 

In cancer cells, excessive activation of this pathway may promote survival and adaptation to adverse conditions. At the same time, NF-κB is essential for normal cell function, so the goal is not to switch it off completely but rather to modulate its activity as precisely as possible. 

Cancer cells struggled more with energy depletion 

The tested compounds disrupted mitochondrial function, reducing the cells’ ability to produce energy. 

In fibrosarcoma cells, ATP levels decreased by approximately 83–92%, compared with reductions of around 23–73% in healthy muscle cells. This suggests that cancer cells are more vulnerable to disturbances in energy metabolism. 

The compounds also affected mitophagy, the process responsible for removing damaged mitochondria. 

Berberine, cucurbitacin E and CAPE enhanced PINK1/PARKIN-dependent mitophagy in fibrosarcoma cells. Combined with the marked reduction in ATP levels, this indicates not a protective response but an overwhelmed adaptive mechanism leading to cellular senescence and death, - says Prof. Julita Kulbacka. 

Cancer cells stopped dividing 

All five compounds induced features of cellular senescence in fibrosarcoma cells. In this state, cells remain alive but permanently lose their ability to divide. 

The strongest effect was observed with curcumin. The proportion of senescent cancer cells increased from approximately 16.5% to more than 75%. For the other compounds, the percentage exceeded 66% as well. 

Healthy muscle cells generally showed a weaker response, suggesting a degree of selectivity towards cancer cells. 

Curcumin showed the best overall balance 

Cell viability experiments demonstrated that curcumin and CAPE exhibited the greatest selectivity against fibrosarcoma cells. Curcumin combined strong anticancer activity with induction of cellular senescence while maintaining a relatively favorable safety profile. 

Our findings show that these natural compounds can selectively place a greater metabolic burden on cancer cells than on healthy cells by disrupting mitochondrial function and energy metabolism. Among the compounds tested, curcumin demonstrated the most balanced profile, - emphasizes Prof. Julita Kulbacka. 

Berberine was also well tolerated, although its effects on the mitochondria of healthy muscle cells require further investigation. 

Effectiveness alone is not enough. 

To assess safety, the researchers also used greater wax moth (Galleria mellonella) larvae as an initial toxicity model. 

Berberine and curcumin were the best-tolerated compounds. CAPE and cucurbitacin E caused higher mortality, while biochanin A proved to be the most toxic. 

These findings demonstrate that strong anticancer activity alone is not sufficient for a compound to become a promising drug candidate. Safety for the whole organism is equally important. 

This is not yet a treatment 

The results do not mean that curcumin, berberine, or any of the other tested compounds can already be used to treat sarcomas. The study was performed using animal cell lines and a simple invertebrate model. 

Our findings come from laboratory experiments and preliminary tests in wax moth larvae. The next step is to evaluate these compounds in more advanced in vivo models and to better understand their mechanisms of action, optimal dosing and delivery methods, - notes Prof. Kulbacka. 

The study nevertheless identifies the compounds that deserve further investigation and highlights why the evaluation of natural anticancer agents should consider not only their effectiveness against cancer cells but also their effects on healthy tissues and the organism as a whole. 

Did you know? 

  • Sarcomas account for less than 1% of all cancers in adults but include more than 100 different disease subtypes. 

  • There is no single treatment that works for all sarcomas. Different subtypes often require different therapeutic approaches. 

  • Cancer cells consume much more energy than most healthy cells. 

  • When their “power plants”—the mitochondria—stop functioning properly, their ability to grow and divide is impaired. 

  • Natural compounds may inspire the development of future medicines, but they are not therapies on their own. 

 

Greener route to acne-care ingredients shows why more antioxidants do not always make a better product




KeAi Communications Co., Ltd.
Graphical abstract 

image: 

Graphical abstract

view more 

Credit: Minh Hien Nguyen, Minh-Tri Le, Khac-Minh Thai, Soo-Yeon Lee, Jin-Han Park





A greener extraction method can concentrate antioxidant compounds from medicinal plants, but the more highly enriched fraction may not necessarily be the safest or most practical ingredient for skincare products, according to a study published in the Journal of Dermatologic Science and Cosmetic Technology.

The researchers investigated a blend of four plants used in East Asian medicine and cosmetics: Houttuynia cordata, Scutellaria baicalensis, Chamaecyparis obtusa and Artemisia capillaris. They compared the crude herbal extract with fractions produced using an ethanol–ammonium sulphate aqueous two-phase system (ATPS), a liquid-separation method designed to reduce reliance on conventional organic solvents.

ATPS selectively concentrated phenolic and flavonoid compounds while reducing triterpenes. The best-performing fraction contained 690.8 milligrams of gallic acid equivalents and 42.6 milligrams of quercetin equivalents per gram. It also recorded substantially stronger free-radical scavenging activity than the crude extract, with a DPPH IC50 of 10.67 micrograms per millilitre compared with 50.18.

Biological tests, however, revealed in zebrafish larvae the crude extract was tolerated at higher concentrations and provided stronger protection against hydrogen peroxide-induced oxidative stress. Notably, at 50 micrograms per millilitre, it increased expression of the antioxidant-related gene prdx1 by approximately 1.44-fold, while leaving gstp1 expression broadly unchanged.

Based on this safety profile, the researchers used the crude extract to formulate a foaming cleanser and a spot-gel serum. Both remained physically stable over four weeks at 4 oC, 25 oC and 40 oC. The cleanser inhibited Cutibacterium acnes and Staphylococcus epidermidis, producing inhibition zones of 33.5 and 24.0 millimetres respectively. It also strongly suppressed biofilm formation in both single- and mixed-species cultures. The serum showed no detectable antibacterial activity.

The findings suggest that chemical antioxidant potency alone is insufficient for selecting cosmetic ingredients. Biological safety, formulation chemistry and microbial interactions should be considered too.

###

Contact authors:

Minh Hien Nguyen

Department of Organic and Medicinal Chemistry, Faculty of Pharmacy, University of Health Sciences, Ho Chi Minh City 75308, Vietnam

Research Center for Discovery and Development of Healthcare Products, Vietnam National University, Ho Chi Minh City 71309, Vietnam

Vietnam National University Ho Chi Minh City, Ho Chi Minh City 71309, Vietnam

nmhien@uhsvnu.edu.vn

Jin-Han Park

Department of Cosmetic Science, Daegu Haany University, Gyeongbuk 38610, Republic of Korea

jinhan@dhu.ac.kr

The publisher KeAi was established by Elsevier and China Science Publishing & Media Ltd to unfold quality research globally. In 2013, our focus shifted to open access publishing. We now proudly publish more than 200 world-class, open access, English language journals, spanning all scientific disciplines. Many of these are titles we publish in partnership with prestigious societies and academic institutions, such as the National Natural Science Foundation of China (NSFC).

 

Empty seashells became new habitats 470 million years ago




Estonian Research Council






An international study led by researchers from the University of Tartu shows that approximately 470 million years ago, a significant ecological change took place in the world’s oceans: for the first time, the interiors of empty mollusc shells began to be used as habitats. This marked the emergence of a new ecological niche and was a crucial step in the development of a marine ecosystem similar to today’s.

In modern seas, empty mollusc shells rarely remain unoccupied for long. They are often covered with various attached invertebrates, such as bryozoans and annelids. However, the study shows that during the Cambrian Period, more than 500 million years ago, the interiors of such shells remained completely uninhabited, even though organisms living in sheltered cavities already existed.

A team of researchers, including Olev Vinn, Oive Tinn, Liisa Lang, and Mare Isakar from the University of Tartu, analyzed fossils from different parts of the world and found that the first animals to colonize these sheltered habitats appeared in mollusc shells during the Middle Ordovician, or about 460 million years ago. Initially, the relatively large and spacious shells of cephalopods—or nautiloids—were colonized, and later, these small inhabitants also spread into the interiors of snails and clams.

By the Late Ordovician—about 450 million years ago—the interiors of many shells were already densely covered with attached fauna. These were inhabited by animals that filtered food particles floating in the water, such as bryozoans, brachiopods, sponges, graptolites, and cornulids, which built tube-shaped shells.

However, not all empty shells provided the same living conditions. The study revealed that although the communities living in the shells of snails, clams, and cephalopods were quite similar in terms of species composition, the shape of the shells influenced how numerous the organisms were and how large they grew. Water circulated more freely in the spacious chambers of the nautiloids, supplying the animals with oxygen and food and carrying away metabolic waste. Consequently, it is precisely in these shells that the most diverse fossil communities are found.

In the coiled shells of snails with narrow openings, water exchange was poorer, and the organisms that grew there were mostly smaller; moreover, some animal groups requiring a stronger water current were entirely absent.

Why did this new way of life emerge during the Ordovician?

The adoption of this new habitat coincided with a major increase in Ordovician biodiversity. At that time, marine communities diversified rapidly, and there was a significant increase in the number of sessile organisms encrusting skeletal substrates compared to earlier periods.

Several factors contributed to the spread of this new habitat: increased predation pressure, the rapid diversification of sessile organisms, and the enlargement of mollusc shells throughout the Ordovician. The sheltered interiors of the shells provided protection for the animals and open space for sessile fauna to attach to the hard surface. The interior of an empty shell also offered protection to delicate filter-feeders against both predation and physical disturbances.

The oldest known inhabitants of empty shells have been found in the Baltica region, which may indicate that this new way of life first emerged in these seas. However, the researchers emphasize that this result may also be partly due to the fact that fossils from Estonia and other parts of Baltica have been thoroughly studied.

By the end of the Ordovician, similar communities were already present in Laurentia—present-day North America—as well as in southern China and the Gondwana region. For this reason, the authors view the colonization of empty shells as a global ecological event.

The study helps us better understand how ecological innovations have shaped the evolution of life on Earth. Even a seemingly modest change—the adoption of empty shells as habitats—may have had a significant impact on the development of seafloor ecosystems and the growth of biodiversity hundreds of millions of years ago.

The study “Colonization of empty shells by cryptic fauna: a global event and important ecological innovation in Ordovician benthic ecosystems” was published in the journal Scientific Reports.